To visit the old Ventura website, click here.
Ventura Wealth Clients Login here

NSEBSE
NSEBSE
noteThere is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
1D
1W
1M
1Y
3Y
5Y
Max
Open-
High-
Low-
Prev. Close-
Avg. Traded Price-
Volume-

MARKET DEPTH

info2
Total bid0.00
Total ask0.00
OrdersQtyBid
AskQtyOrders

HIGH/LOW

info2
1d
1w
1m
3m
52w

LOW/HIGH

1,992.30a day ago
2,046.50a day ago
arrow

LOWER/UPPER CIRCUITS

1,596.30
2,394.30
arrow
Metropolis Healthcare Ltd Stock performance
arrow

KEY OBSERVATIONS

info
positive
negative
neutral
noteAnnual Revenue,rose 10.64%, in the last year to ₹1,346.32 Cr. Its sector's average revenue growth for the last fiscal year was 16.24%.
noteAnnual Net Profit,rose 13.42% in the last year to ₹144.97 Cr. Its sector's average net profit growth for the last fiscal year was 58.45%.
noteQuarterly Revenue,rose 4.32% YoY to ₹352.26 Cr. Its sector's average revenue growth YoY for the quarter was 15.5%.
View more

LONG-TERM PRICE ANALYSIS

info
Stock return5Y CAGR : %
Net profit growth 5Y CAGR : 0.54%
Metropolis Healthcare Limited is engaged in the business of providing pathology and related healthcare services. The profile comprises of a variety of test combinations which are specific to a disease or disorder as well as wellness profiles that are used for health and fitness screening. It classifies its tests into ‘routine’ tests such as blood chemistry analyses, blood cell counts and urine examination; ‘semi-specialized’ tests such as thyroid function tests, viral and bacterial cultures, histology, cytology and infectious disease tests; and ‘specialized’ tests such as tests for coagulation studies, autoimmunity tests, cytogenetics and molecular diagnostics. It is focused on providing reliable test results as well as value-added services such as home collection of specimens and online access to test reports. It also offers customized wellness packages to its institutional customers as per their requirement.
personal

Grow your wealth with more research recommendations

+91